Aalborg

• Can treatment with tirzepatide reduce alcohol intake in individuals diagnosed with schizophrenia and alcohol use disorder (DUALPSYCHIATRY) Recruiting
  2024-518608-28-00 4 2025-05-01 Schizophrenia and Alcohol Use Disorder
• Comparing the Efficacy and Safety of Aspirin Alone versus Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction ( … Recruiting
  2024-517229-18-00 11 2025-04-30 Non-ST-Elevation Myocardial Infarction (NSTEMI)
• Klinefelter syndrome – the effect of Testosterone treatment In PubertY A randomized, double-blind placebo-controlled intervention study ‘Th … Recruiting
  2023-505854-16-00 6 2025-04-01 47,XXY (Klinefelter syndrome)
• A clinical study of zilovertamab vedotin in people with large B-cell lymphoma (MK-2140-010) Recruiting
  2024-515566-13-00 5 2025-03-19 Diffuse Large B-Cell Lymphoma (DLBCL)
• Thrombolysis in Factor Xa-inhibitors Trial (SIFT) Recruiting
  2023-509907-34-01 5 2025-03-10 acute ischemic stroke
• A trial to learn if AZD0486 alone or with other anticancer drugs is safe and works in adults with certain blood cancers Recruiting
  2024-515034-33-00 9 2025-03-05 Mantle Cell Lymphoma
• Study of MK-5684-based Therapies in Advanced Prostate Cancer Recruiting
  2023-506288-33-00 9 2025-03-03 Metastatic castration resistant prostate cancer (mCRPC)
• FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: a multicenter randomized clinical trial (MONITOR-RCT) Recruiting
  2023-508591-11-00 5 2025-02-25 Metastatic breast cancer
• Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Ca … Recruiting
  2022-502352-31-00 5 2025-02-10 Colorectal Cancer (CRC)
• A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext … Recruiting
  2022-502877-41-01 9 2025-02-10 Pulmonary sarcoidosis with or without extrapulmonary manifestations
• A randomized phase III trial with lomustine versus lomustine and bevacizumab for patients with recurrent glioblastoma Recruiting
  2024-519437-27-02 5 2025-02-03 Glioblastoma
• ALEXIS Recruiting
  2023-510042-24-01 6 2025-01-30 osteoporosis
• FAPI PET in Pleural Mesothelioma Recruiting
  2024-514301-62-00 4 2025-01-29 Pleural Mesothelioma
• Prednisone treatment in acute interstitial nephritis (PRAISE) Recruiting
  2024-520299-86-00 6 2025-01-22 Acute interstitial nephritis
• Gabapentin for nerve pain in the leg from the lower back Recruiting
  2023-508537-13-01 5 2025-01-20 radicular leg pain
• REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting
  2024-514312-27-00 6 2025-01-07 Bacterial infection
• A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting
  2023-508191-11-00 5 2024-11-28 Systemic lupus erythematosus (SLE)
• An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma Recruiting
  2024-512113-41-00 5 2024-11-20 Severe Asthma
• A study to learn more about how well sevabertinib works and how safe it is compared with standard treatment, in participants who have advanc … Recruiting
  2024-511319-91-00 5 2024-10-23 Advanced non-small cell lung cancer with HER2 (ERBB2) mutation
• New Beacon Recruiting
  2024-518419-20-00 4 2024-10-23 BRAF V600E mutated colorectal cancer
• A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CO … Recruiting
  2023-508760-29-00 5 2024-10-21 Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
• VEX-AZA: Treating VEXAS Syndrome with Azacitidine. A Single-Arm, Multicenter Phase II Study on the Efficacy and Safety of Azacitidine in Pat … Recruiting
  2024-510715-30-00 4 2024-09-26 VEXAS
• Local Antibiotics for Women Undergoing Breast Reconstruction Surgery with Implants Recruiting
  2024-517672-38-00 5 2024-09-20 Infection
• A Phase 2b Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects with Moderately to Severely Active Crohn’s Disease Recruiting
  2023-506704-14-00 4 2024-09-04 Moderately to Severely Active Crohn's Disease

Showing 97–120 of 319 trials